| 3902 | A | 074132 | 002 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | TEVA | EQ 25MG BASE | AB | ["AB"] | 1995-03-27 | Mar 27, 1995 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | dc858ee7750497ed9773d103d3131403061bb5ea6bf9deaee5cb3092bbd50a4d |
| 3903 | A | 073667 | 003 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | TEVA | EQ 50MG BASE | | [] | 1996-04-11 | Apr 11, 1996 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | 716ea28bcd69db1521c48890cf7b6bb4b07bf5b9a601e836b3c55380cd65f6db |
| 3904 | A | 074132 | 003 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | TEVA | EQ 50MG BASE | AB | ["AB"] | 1995-03-27 | Mar 27, 1995 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | fc96c8bc01e9eaa3115530f5e2af29d6b1ca23883788156d830513b4e1f21679 |
| 3905 | A | 073667 | 004 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | TEVA | EQ 75MG BASE | | [] | 1996-04-11 | Apr 11, 1996 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | 46ef40fb61fb426656c67e84fca88d1fe551d0617ef43a0ed085378ce22cd76d |
| 3906 | A | 074132 | 004 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | TEVA | EQ 75MG BASE | AB | ["AB"] | 1995-03-27 | Mar 27, 1995 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | c57cd09b23aaa9c0ebd9225d2186ec7e6c961564a9e4d3bb68264c5e8cb25ee7 |
| 3907 | A | 213441 | 001 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | ZYDUS | EQ 10MG BASE | AB | ["AB"] | 2021-02-24 | Feb 24, 2021 | No | No | No | RX | ZYDUS WORLDWIDE DMCC | 90f2acaec61126b41ca9d9cc1e3a8504168bf1d01f8b94400e9cc48570e7cff8 |
| 3908 | A | 213441 | 002 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | ZYDUS | EQ 25MG BASE | AB | ["AB"] | 2021-02-24 | Feb 24, 2021 | No | No | No | RX | ZYDUS WORLDWIDE DMCC | 4da761c683c12ed3a6b6a75f179d3e73a794a34517348f6c199b07f661f49ed9 |
| 3909 | A | 213441 | 003 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | ZYDUS | EQ 50MG BASE | AB | ["AB"] | 2021-02-24 | Feb 24, 2021 | No | No | No | RX | ZYDUS WORLDWIDE DMCC | fbc5ead43c49a63c78c040d5c07ba0cf2361cbd527fbaa1f5e388eb4b3faa612 |
| 3910 | A | 213441 | 004 | NORTRIPTYLINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | NORTRIPTYLINE HYDROCHLORIDE | ZYDUS | EQ 75MG BASE | AB | ["AB"] | 2021-02-24 | Feb 24, 2021 | No | No | No | RX | ZYDUS WORLDWIDE DMCC | 6db34ea34ee28812967baa290a1310670c42ef9619fcf47030f46d14d352bc90 |
| 3911 | N | 020680 | 001 | RITONAVIR | CAPSULE;ORAL | CAPSULE | ORAL | NORVIR | ABBOTT | 100MG | | [] | 1996-03-01 | Mar 1, 1996 | No | No | No | DISCN | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | 2265e1cb6b2303dca16f6a3105b90cba644f76019c7fd9c26ffbc4126115cb10 |
| 3912 | N | 020945 | 001 | RITONAVIR | CAPSULE;ORAL | CAPSULE | ORAL | NORVIR | ABBVIE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1999-06-29 | Jun 29, 1999 | No | Yes | No | DISCN | ABBVIE INC | 578473253566ccd04cd826ec363986d56f13a195fe35c4f9984783df1ccd471c |
| 3913 | N | 012928 | 006 | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS | CAPSULE;ORAL | CAPSULE | ORAL | NOVRAD | LILLY | EQ 50MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ELI LILLY INDUSTRIES INC | 5426b07311df141c83acda9990090f5ae3ca65114068b561cd7f56f270cc2ad3 |
| 3914 | N | 012928 | 004 | LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS | CAPSULE;ORAL | CAPSULE | ORAL | NOVRAD | LILLY | EQ 100MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | ELI LILLY INDUSTRIES INC | 6c119db71b1b728a33cb0286039fd5caebdcdefb838043e87503e7d596371b29 |
| 3915 | N | 021879 | 001 | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | CAPSULE;ORAL | CAPSULE | ORAL | NUEDEXTA | AVANIR PHARMS | 20MG;10MG | AB | ["AB"] | 2010-10-29 | Oct 29, 2010 | No | Yes | Yes | RX | AVANIR PHARMACEUTICALS INC | b05860f8d650dbffe393c3f4057d7a343fc850a4ac8cfb987216f155cce1bda4 |
| 3916 | N | 210793 | 001 | PIMAVANSERIN TARTRATE | CAPSULE;ORAL | CAPSULE | ORAL | NUPLAZID | ACADIA PHARMS INC | EQ 34MG BASE | | [] | 2018-06-28 | Jun 28, 2018 | No | Yes | Yes | RX | ACADIA PHARMACEUTICALS INC | 869a69251bd71972ade8421788067c3c5bfc128fdec326d869b3dacb6b09430c |
| 3917 | A | 087144 | 001 | PHENTERMINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | OBESTIN-30 | FERNDALE LABS | 30MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | FERNDALE LABORATORIES INC | 6957237c12d8ee01af2a6e9d7c056b0b619a79b55b08d2b01fcbad4e9f8f7bb1 |
| 3918 | A | 087764 | 001 | PHENTERMINE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | OBY-TRIM | SHIRE RICHWOOD | 30MG | | [] | 1982-03-18 | Mar 18, 1982 | No | No | No | DISCN | SHIRE RICHWOOD INC | c6ff93a1ef483cc17dd98d2b444ee196315fbdee94b8b5030ea7ecb808459740 |
| 3919 | N | 205266 | 001 | SONIDEGIB PHOSPHATE | CAPSULE;ORAL | CAPSULE | ORAL | ODOMZO | SUN PHARMA GLOBAL | EQ 200MG BASE | | [] | 2015-07-24 | Jul 24, 2015 | No | Yes | Yes | RX | SUN PHARMA GLOBAL FZE | 4e685803b17ef9dea48ad4817c6489fd32aeaf494af9b4f2ef0a30287fc37620 |
| 3920 | N | 205832 | 001 | NINTEDANIB ESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | OFEV | BOEHRINGER INGELHEIM | EQ 100MG BASE | | [] | 2014-10-15 | Oct 15, 2014 | No | Yes | No | RX | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 33a616fccdd8f4a7ee80a23700e1a2ad5aa6bec047537fba43cbd28a9919d10a |
| 3921 | N | 205832 | 002 | NINTEDANIB ESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | OFEV | BOEHRINGER INGELHEIM | EQ 150MG BASE | | [] | 2014-10-15 | Oct 15, 2014 | No | Yes | Yes | RX | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 1d031a2be3a89a244387e5a197b107dbce7d6605d787f52bbe717d884fe92da0 |
| 3922 | A | 077742 | 001 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | PAR PHARM | EQ 25MG BASE;EQ 3MG BASE | AB | ["AB"] | 2012-11-02 | Nov 2, 2012 | No | No | No | RX | PAR PHARMACEUTICAL INC | 1bc0253a151a0cef5a3f83eeb37c44109822a16b0d142d3565f139ceb84bae9b |
| 3923 | A | 077742 | 002 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | PAR PHARM | EQ 25MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-11-02 | Nov 2, 2012 | No | No | No | RX | PAR PHARMACEUTICAL INC | c7c3a04e6ca092bc4c386ae38f7dc5efc638fb9767cc939e584eb3fbb386581c |
| 3924 | A | 077742 | 003 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | PAR PHARM | EQ 25MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-11-02 | Nov 2, 2012 | No | No | No | RX | PAR PHARMACEUTICAL INC | a4dad5236689b3c3326c76b19044751d998427a11b1441f68c5928ad00f38e2f |
| 3925 | A | 077742 | 004 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | PAR PHARM | EQ 50MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-11-02 | Nov 2, 2012 | No | No | No | RX | PAR PHARMACEUTICAL INC | 9b7094aabdfd4595b90ccc2cfb24e28170fb8e90fa95ba033bbbb5bb00d22326 |
| 3926 | A | 077742 | 005 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | PAR PHARM | EQ 50MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-11-02 | Nov 2, 2012 | No | No | No | RX | PAR PHARMACEUTICAL INC | 96da889ed7f8002d8e3ba64dd4f44fa415ff5295a0f88c28aabbe0ec78a4e4be |
| 3927 | A | 078901 | 005 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | SANDOZ | EQ 25MG BASE;EQ 3MG BASE | AB | ["AB"] | 2012-11-16 | Nov 16, 2012 | No | No | No | RX | SANDOZ INC | c47392790b4c2ae5418fd5eadd870db357dc44fe92f2442a328d150a9de4e946 |
| 3928 | A | 078901 | 001 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | SANDOZ | EQ 25MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-11-16 | Nov 16, 2012 | No | No | No | RX | SANDOZ INC | 5f90bb4682069d07e28ae2b4d917c2dbaa36404b1cb51ee64c7f4d76e1c06cb6 |
| 3929 | A | 078901 | 003 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | SANDOZ | EQ 25MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-11-16 | Nov 16, 2012 | No | No | No | RX | SANDOZ INC | 8b6de1169aaa0dfd2453396f7f9af718c2d0852a014a9252872f16b9f5d4b9e1 |
| 3930 | A | 078901 | 002 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | SANDOZ | EQ 50MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-11-16 | Nov 16, 2012 | No | No | No | RX | SANDOZ INC | 01a8c77d6fd2bd747fbb5b30a06ae5b97d16247928d27eebab542df248cd6524 |
| 3931 | A | 078901 | 004 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | SANDOZ | EQ 50MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-11-16 | Nov 16, 2012 | No | No | No | RX | SANDOZ INC | 5d011265f7f035e6a667a129be37cb893e855b8b02d17d565401f582507de53a |
| 3932 | A | 202074 | 001 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | TEVA PHARMS | EQ 25MG BASE;EQ 3MG BASE | AB | ["AB"] | 2013-03-25 | Mar 25, 2013 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 0a0c9c7442e093996878df2f800928f3b15fb1b3f6c6a484977a68e25c43c412 |
| 3933 | A | 077528 | 001 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | TEVA PHARMS | EQ 25MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-06-19 | Jun 19, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | f851c72293240d74b2a84ffd9a0647cbf20584c5c487fdbd396cd6d04b0b485a |
| 3934 | A | 077528 | 002 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | TEVA PHARMS | EQ 25MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-06-19 | Jun 19, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 0007fd1352d34fc6ce57bcae0b4f1f71f3a765b51a341bb663f6426fb60ca7a4 |
| 3935 | A | 077528 | 003 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | TEVA PHARMS | EQ 50MG BASE;EQ 6MG BASE | AB | ["AB"] | 2012-06-19 | Jun 19, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 5cdb57a3946b1f670c48f624dce09e5674d2fa8ebb2ad4ef95d27f8cd669270c |
| 3936 | A | 077528 | 004 | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | CAPSULE | ORAL | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | TEVA PHARMS | EQ 50MG BASE;EQ 12MG BASE | AB | ["AB"] | 2012-06-19 | Jun 19, 2012 | No | No | No | RX | TEVA PHARMACEUTICALS USA | e72632c6ae681973f10c4d59ebe96bc00dfeb4481e30cb616041bdaf1a903456 |
| 3937 | N | 205123 | 001 | SIMEPREVIR SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | OLYSIO | JANSSEN PRODS | EQ 150MG BASE | | [] | 2013-11-22 | Nov 22, 2013 | No | Yes | No | DISCN | JANSSEN PRODUCTS LP | 616d395bd1e97bd73405d8240f2d7d24a6e5cdeb16be1193b5d459ffefc77d64 |
| 3938 | A | 204940 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | AMNEAL PHARMS | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2015-11-27 | Nov 27, 2015 | No | No | No | RX | AMNEAL PHARMACEUTICALS OF NEW YORK LLC | 32b61b8090ca3be9f69a1261eeb68345b9859da7948c4872e59cae3d2e48effb |
| 3939 | A | 090973 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | APOTEX | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2014-09-30 | Sep 30, 2014 | No | No | No | RX | APOTEX INC | f655bb3aace8963efb318fa4cea2ab752d040af23bc50cc87e646162a6168f9e |
| 3940 | A | 207420 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | ASCENT PHARMS INC | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2019-02-25 | Feb 25, 2019 | No | No | No | RX | ASCENT PHARMACEUTICALS INC | be0e46e7c45cbed725e73d1b65c43d698cb7bd04f9ccd3c9c56a6391aa11ddbe |
| 3941 | A | 206455 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | BIONPHARMA INC | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2019-08-07 | Aug 7, 2019 | No | No | No | RX | BIONPHARMA INC | 6a2acb615e74ac29003bb20c1739742b927ab0096b833c3551f2b6cff02a552f |
| 3942 | A | 211979 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | CSPC-NBP PHARM | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2020-05-12 | May 12, 2020 | No | No | No | RX | CSPC-NBP PHARMACEUTICAL CO LTD | c5617a352b7518795bdaac8a0fef11740e2de42b13216b75d3eeaf2f486eec8c |
| 3943 | A | 212504 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | GLW | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2020-08-19 | Aug 19, 2020 | No | No | No | RX | GLW PHARMA GMBH | ce09b2713bf750bed47c2903c7d162b638a03cc79395828b09b58bf2a68d903c |
| 3944 | A | 091018 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | PAR PHARM INC | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | | [] | 2014-06-24 | Jun 24, 2014 | No | No | No | DISCN | PAR PHARMACEUTICAL INC | 650d722545f0a5efb27930112f2de0b5bc19847f3e9275b3c1e7655f4af6637f |
| 3945 | A | 210093 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | PURACAP PHARM LLC | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2020-06-15 | Jun 15, 2020 | No | No | No | RX | PURACAP PHARMACEUTICAL LLC | f9e52d09b9d5a0eb101cdf2ea13ef7b15d81cb6f9d86018b57621b269dee117d |
| 3946 | A | 211355 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | SOFGEN PHARMS | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2019-07-10 | Jul 10, 2019 | No | No | No | RX | SOFGEN PHARMACEUTICALS LLC | 6301443bb5ca4b00a44a866fe17cd7f67503f577d0178c9323607e2059ea2226 |
| 3947 | A | 203893 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | STRIDES PHARMA | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2017-09-19 | Sep 19, 2017 | No | No | No | RX | STRIDES PHARMA GLOBAL PTE LTD | 9a6b223ce3260e288f9bdfb43230b60a27e68bca474bf4a0f92b9dd39f66f215 |
| 3948 | A | 210834 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | SUN PHARM | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2020-01-09 | Jan 9, 2020 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | d49fee60610bb4138e693a223583c9188cd36d245deb203108ed7a366fc23fa4 |
| 3949 | A | 091028 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | TEVA PHARMS USA | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | AB | ["AB"] | 2014-04-07 | Apr 7, 2014 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 6298f2416be7b829b77d006f8c04b1f8dcdb3b4cfb103dc55d2ae0db7ac0e12e |
| 3950 | A | 210107 | 001 | OMEGA-3-ACID ETHYL ESTERS | CAPSULE;ORAL | CAPSULE | ORAL | OMEGA-3-ACID ETHYL ESTERS | ZYDUS | 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS | | [] | 2019-06-14 | Jun 14, 2019 | No | No | No | DISCN | ZYDUS WORLDWIDE DMCC | a128071c116dff8f27e44d70958a22ee99766212051af64752c0dd571e4df89d |
| 3951 | A | 204228 | 001 | OMEPRAZOLE; SODIUM BICARBONATE | CAPSULE;ORAL | CAPSULE | ORAL | OMEPRAZOLE AND SODIUM BICARBONATE | AJANTA PHARMA LTD | 20MG;1.1GM | AB | ["AB"] | 2016-07-15 | Jul 15, 2016 | No | No | No | RX | AJANTA PHARMA LTD | 895b2e0c4cd7570456c415f5f631b3f66d28957b2d8b600958fe1a1b3568e24c |